NovelBeam Technology(SH:688677) Zhong Guo Zheng Quan Bao·2025-07-31 23:25Core Viewpoint - Haitai Newlight is leading significant innovations in the endoscope industry with its first LED light source, first fluorescence endoscope, and first optical de-fogging system, positioning itself as a key player in the medical device market [2][3]. Company Background - Haitai Newlight transitioned from micro-projection display technology to the medical endoscope sector, leveraging its deep understanding of optical technology [3]. - The company established a strong partnership with global leaders in the endoscope market, which accelerated its innovation momentum [4]. Technological Innovations - The introduction of LED light sources has significantly improved brightness by over 20% compared to traditional xenon lamps, marking the entry of endoscopes into the LED era [3]. - Haitai Newlight developed the world's first coaxial fluorescence endoscope, enhancing surgical accuracy by allowing visualization of structures beneath the skin [5]. - The company launched the first optical de-fogging endoscope system in 2023, utilizing specific light to achieve thermal balance and eliminate fog [5]. Market Strategy - Haitai Newlight aims to build its own brand in the domestic market, having initiated brand development and marketing strategies since 2018 [8]. - The company has established a marketing team and centers across key provinces to facilitate clinical trials and product testing in hospitals [8][9]. - The domestic market share of international giants has decreased from 70%-80% to around 50% due to the rise of local brands [8]. Future Outlook - The company plans to expand its product line and integrate AI and robotic technologies to enhance its offerings [6][11]. - Haitai Newlight's development strategy includes deepening its core product capabilities while broadening its product line to meet diverse medical needs [11].